This study tested the hypothesis that RHAMM deletion enhances hepatic antioxidant defenses by increasing Nrf2 activity, alleviating obesity-induced hepatic oxidative stress and restoring thyroid hormone homeostasis. Here, TG is linked to obesity due to melanocortin 4 receptor deficiency.